Clovis Oncology halts mid-stage bladder cancer trial, shares drop

73

Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

http://feeds.reuters.com/~r/reuters/healthNews/~3/hc9cSRDd_fo/clovis-oncology-halts-mid-stage-bladder-cancer-trial-shares-drop-idUSKCN1RO2O2